Atopic Dermatitis
Conference Coverage
Which Tools Are Best to Streamline In-Office Assessments of Eczema Patients?
Choose an assessment tool that works for you within your practice setting.
From the Journals
Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque Psoriasis
PDE4 inhibitors are a promising therapeutic target for inflammatory diseases because “they can increase cyclic adenosine monophosphate levels and...
Conference Coverage
Expert Frames Factors to Consider Among Atopic Dermatitis Treatment Options
“There isn’t going to be a one-size-fits-all approach.”
Latest News
‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials
“This is the longest safety study ever published for any systemic drug for AD,” Christopher G. Bunick, MD, said.
Conference Coverage
What’s the Real Prevalence of Conjunctivitis in AD Patients Treated With Dupilumab?
“About 2% of people treated with dupilumab are going to get clinically very meaningful conjunctivitis that may be therapy limiting.”
Latest News
‘Real-World’ Registry Study of Upadacitinib Supports Clinical Trial Data
“We know from clinical trials that upadacitinib is effective, but we have very little real-world experience on its effectiveness,”...
Latest News
Paradoxical Eczema Risk Low With Biologic Psoriasis Treatments
The study included data for all currently available biologics, “originating from more than 160 dermatology centers in the UK and Ireland,” the...
Latest News
How does lebrikizumab perform across different racial and ethnic subgroups?
Prior use of systemic therapy was lower in the Black and “other” subgroups, compared with other racial subgroups.
Latest News
Tape strips detect hidradenitis suppurativa biomarkers, novel study shows
The analysis is believed to be the first of its kind.
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Latest News
Parent concerns a factor when treating eczema in children with darker skin types
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...